This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03464/identifier/pdb/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03464/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03464/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03464/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03464
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB03464 n13:DB03464
dcterms:title
Formycin-5'-Monophosphate
adms:identifier
n9:46936686 n10:46508644 n11:DB03464 n12:FMP
n5:IUPAC-Name
n6:271B4AA7-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4AAD-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4AAC-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4AA9-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4AAA-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4AAB-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4AA5-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4AA3-363D-11E5-9242-09173F13E4C5 n6:271B4AA6-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4AA4-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4AB3-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4AB4-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4AAE-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4AAF-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4AB1-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4AB0-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4AB2-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4AB9-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4ABB-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4ABC-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4AB8-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4AB7-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4ABA-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4AA8-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4AB5-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4AB6-363D-11E5-9242-09173F13E4C5